Enclusa Therapeutics LLC - Menlo Park, California 94025

Enclusa Therapeutics LLC is categorized under Commercial Biotechnical Research in Menlo Park, CA .

Business Name: Enclusa Therapeutics LLC
Contact Person: Jack Lin
Address: 3475 Edison Way # J, Menlo Park, California 94025
Phone Number: (650) 209-0988
Annual Revenue (USD): $50.000 to $99.999
Founding Year: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:
Related Businesses: Primal Therapies Inc - Menlo Park, CA 94025
Circuit Therapeutics, Inc. - Menlo Park, CA 94025
Cardiokinetix Inc - Menlo Park, CA 94025
Theraject - Menlo Park, CA 94025
Primax Biosciences Inc - Menlo Park, CA 94025
Phyllom - Menlo Park, CA 94025
Advansta Inc - Menlo Park, CA 94025
Rational Biotechnology Inc - Menlo Park, CA 94025
Blanca Pharmaceuticals LLC - Menlo Park, CA 94025
Brown Resource Group - Menlo Park, CA 94025
H W Chang - Menlo Park, CA 94025
Shengnuo Peptide Usa Inc - Menlo Park, CA 94025
Dice Molecules Corporation - Menlo Park, CA 94025
Leonardo Innovations - Menlo Park, CA 94025
Circuit Therapeutics Inc - Menlo Park, CA 94025
3-V Biosciences Inc - Menlo Park, CA 94025

The company Enclusa Therapeutics LLC provides B2B services in the form of Commercial Biotechnical Research from its single location in California. 1 to 4 employees work for Enclusa Therapeutics LLC, and the business now earns $50.000 to $99.999 per annum.

Enclusa Therapeutics LLC was launched in 2012 and is classified under SIC code and category 8731 , and NAICS number and grouping 541711 . To contact Enclusa Therapeutics LLC, please call Jack Lin with the phone number (650) 209-0988 or visit its single location at 3475 Edison Way # J in Menlo Park, California 94025.

The location of the single location can also be found using the coordinates 37.476646,-122.197959. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.